Oral HF - Other

454 - NT-proBNP Levels Are Reduced Following Treatment With Growth Hormone in Chronic Heart Failure Due to Ischemic Heart Disease. A Randomized Double Blind Placebo Controlled Trial

Presentation Number
454
Presenter
Co-Authors

Previous Eposter
412 - Survival and Graft Function in Heart Transplant Patients Receiving Adverse Risk Profile Donor Hearts

Next Eposters
31 - Mitochondrial Transplantation Prolongs Cold Preservation Time in Murine Cardiac Transplantation
282 - Frailty Assessment in Lung Transplant Candidates: The Use of the Short Performance Physical Battery
476 - Transplant Outcomes of Adult Donor Hearts with Prior Quality-based Offer Refusals
234 - A Comparison of Surgical Outcomes for LVAD Implantation by Minimally Invasive Surgery and Conventional Sternotomy
90 - Pulmonary Dynamic Compliance for Prediction of Mortality in Adult Severe Acute Respiratory Distress Syndrome Treated With Veno-Venous Extracorporeal Membrane Oxygenation
479 - Bronchoalveolar Lavage Practices in Lung Transplantation: Results of a Large-scale International Survey
281 - A Single Centre UK Experience of Incorporating Urgently Listed Inotrope and Ventricular Assist Device Patients into a Cardiac Rehabilitation Programme Pre-Transplant
253 - Panel Reactive Antibodies and Outcomes Following Heart Transplantation in Adults with Congenital Heart Disease
378 - Acute Decompensated Heart Failure in the Pediatric Population: A Report from the Pediatric Cardiac Critical Care Consortium (PC4)
127 - Validity of a Novel Institutional Method to Analyze and Display HeartWare HVAD Log Files